AI Use in Drug Discovery
Data Matters
NOVEMBER 9, 2023
Together, they discuss the challenges and opportunities AI presents for the pharmaceutical industry, particularly how AI is accelerating the pace of drug discovery and its implications for the future of medicine. Join “State of the Art” host and Sidley partner Stephen Abreu as he speaks with Colin Hill , CEO and Co-Founder of Aitia.
Let's personalize your content